BioSig Technologies, Inc. STEX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -627.1%— | —— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 13.9×+12.2× | 1.7×+1.6× | 0.1×+0.1× | 0×-2.3× | 2.4×+2.2× | |
| Per Share | ||||||
| Book value per share | $0.91-67.2% | $2.78+1,431% | -$0.21-59.9% | -$0.13-204% | $0.13+214% | |
| Valuation | ||||||
| Market capitalization | $88.66M-61.8% | $123.64M-39.1% | $203.16M-82.1% | $1.13B+7,820% | $14.31M-44.3% | |
| Price / book | 0.6×— | 0.9×— | —— | —— | 5.5×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioSig Technologies, Inc.'s profit margins?
- BioSig Technologies, Inc. (STEX) runs a 80.1% gross margin and a -32155.0% operating margin, with a -25825.0% net margin.
- Where do BioSig Technologies, Inc.'s ratios come from?
- Every ratio is computed from BioSig Technologies, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
